BLUE IRIS LABS, INC.

Fairfax, CA · Founded 2020 · Medtech · Private

A networked wearable and wall-mounted light spectrometer that measures circadian light exposure and provides remote data collection for monitoring and optimizing lighting conditions.

Claim this profile

Follows are private to you and power your alerts

Updated · blueirislabs.com

Sector
Medtech
Headquarters
Fairfax, CA
Founded
2020
Latest Form D
$800, Jul 2021
Total capital
$3.3M
Federal grants
$3.3M
4 awards · 2021–2023
Rank in peer group#295 of 538
Private capital raised
$800
1 Form D · last Jul 2021
63 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

202120222023FEDERAL ↑EQUITY ↓Cumulative $3.3M$800K$18K$1.2M$1.2M1st Form D$800
202120222023FEDERAL ↑EQUITY ↓Cumulative $3.3M$800K$18K$1.2M$1.2M1st Form D$800

Latest events

  • Federal grantHealth and Human S · Phase II · A light exposure tracker designed to improve the circadian entrainment for Alzheimer Disease patients$1.2M
  • Federal grantHealth and Human S · Phase II · A light exposure tracker designed to improve the circadian entrainment for Alzheimer Disease patients$1.2M
  • Private capital raisedForm D · SEC · 1st filing$800
  • Federal grantHealth and Human S · Phase II · Device to control circadian-effective light in Alzheimer's disease environments$18K
  • Federal grantHealth and Human S · Phase II · Device to control circadian-effective light in Alzheimer's disease environments$800K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

<1months

from BLUE IRIS LABS, INC.’s first federal award to its first private round.

First federal award · Jul 2021
Health and Human S · $800K
First Form D · Jul 2021
$800 · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Erik PageResearcherExecutive Officer, DirectorLinked by $3.3M in grants as PI
  • Neal JacksonExecutive Officer, DirectorNamed in SEC Form D filings
  • William HuangExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .